← Back
$STRO All transactions

SUTRO BIOPHARMA, INC.

M

$ Value

$0

Shares

25,000

Price

$0

Filed

Aug 26

Insider

Name

Leyman Barbara

Title

Chief Business Officer

CIK

0002028309

Roles

Officer

Transaction Details

Transaction Date

2025-07-08

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

75,000

Footnotes

Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. | Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. | The RSUs vest as to 1/4th of the total award annually beginning on July 8, 2025, subject to the reporting person's continued service to the Issuer through each vesting date.

Filing Info

Accession No.

0001415889-25-023084

Form Type

4

Issuer CIK

0001382101

Leyman Barbara's History

Date Ticker Type Value
2025-07-08 STRO M $0
2025-07-08 STRO F $7K
2025-07-08 STRO M $0

Other Insiders at STRO (90d)

Insider Bought Sold Last
Chow Gregory K.
CFO
2026-03-02
Chung Jane
Chief Executive Officer
2026-03-04
Gerber Hans-Peter
CHIEF SCIENTIFIC OFFICER
2026-03-02
Pauling David
Chief Admin. Ofcr. & GC
2026-03-04